Cala Health

About:

Cala Health provides bioelectronic medicines, medical devices, and neurotherapeutics.

Website: http://calahealth.com/

Twitter/X: calahealth

Top Investors: Google Ventures, Lux Capital, Baird Capital, Dolby Family Ventures, Johnson & Johnson Innovation – JJDC

Description:

Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™ therapy, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in Parkinson’s disease and other indications in neurology, as well as targets in psychiatry, cardiology, and autoimmune disorders. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

Total Funding Amount:

$148M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burlingame, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)calahealth.com

Founders:

Kate Rosenbluth, Scott Delp, Serena Wong

Number of Employees:

101-250

Last Funding Date:

2021-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai